288 employees
Ribozyme Pharmaceuticals is a biotechnology company that develops therapeutics based on RNA interference (RNAi) technology.
2005
$12M
from 1 investors over 1 rounds
Rpi raised $12M on July 13, 1999
Investors: Morgenthaler